Chaiqin Chengqi Decoction as an adjuvant treatment for mild/moderately severe hypertriglyceridemic acute pancreatitis: A retrospective study

Figure 1 A flowchart depicting the patient selection process. CQCQD: Chaiqin Chengqi Decoction; TG: Triglyceride.

Figure 2 The alterations in lipid levels pre- and post-treatment. A: Changes in triglyceride (TG), cholesterol and high density lipoprotein cholesterol levels before and after treatment; B: Changes in TG levels before and after treatment in the Chaiqin Chengqi Decoction group; C: Changes in TG levels before and after treatment in the control group; D: Changes in apolipoprotein A1 and apolipoprotein B levels before and after treatment. ^aP < 0.05. TG: Triglyceride; CHO: Cholesterol; HDL-C: High density lipoprotein cholesterol; APOA1: Apolipoprotein A1; APOB: Apolipoprotein B; CQCQD: Chaiqin Chengqi Decoction.

Figure 3 Analysis of bowel recovery and abdominal pain relief. ^aP < 0.05. CQCQD: Chaiqin Chengqi Decoction.

Figure 4 Analysis of acute gastrointestinal injury score and number of bowel movements after treatment. A: Comparison of defecating frequency between the two groups after 3 d of treatment; B: Comparison of acute gastrointestinal injury between the two groups after 3 d of treatment. ^aP < 0.05. AGI: Acute gastrointestinal injury; CQCQD: Chaiqin Chengqi Decoction.

Figure 5 Analysis of duration of symptoms. A: Curves for time without relief from abdominal pain; B: Curves for time without resumption of defecation.

Figure 6 Analysis of the degree of decrease in C-reactive protein. ^aP < 0.05. CRP: C-reactive protein; CQCQD: Chaiqin Chengqi Decoction.

Figure 7 Changes of Balthazar score before and after treatment. CQCQD: Chaiqin Chengqi Decoction.